Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice

Mitochondrion

Volumn 12, Issue 2, 2012, Pages 248-257

  Ziegler, Carly G K ^a   Peng, Min ^a   Falk, Marni J ^b   Polyak, Erzsebet ^b   Tsika, Elpida ^b,c   Ischiropoulos, Harry ^a,b   Bakalar, Dana ^a   Blendy, Julie A ^a   Gasser, David L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EPFL   (Switzerland)

Author keywords

Coenzyme Q; Dopaminergic neurons; Parkinson's disease

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; GENETIC ASSOCIATION; HISTOPATHOLOGY; KNOCKOUT MOUSE; MISSENSE MUTATION; MITOCHONDRIAL RESPIRATION; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; MOUSE MUTANT; MUTATOR GENE; NEUROMUSCULAR DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRENYL DIPHOSPHATE SYNTHASE SUBUNIT 2 GENE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ALKYL AND ARYL TRANSFERASES; ANIMALS; GENE KNOCKOUT TECHNIQUES; HOMOZYGOTE; MALE; MICE; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; MUTANT PROTEINS; MUTATION, MISSENSE; NEUROMUSCULAR DISEASES; PROTEIN SUBUNITS;

MUS;

EID: 84858004895     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.09.011     Document Type: Article

References (26)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Backman C.M., Malik N., Zhang Y., Shan L., Grinberg A., Hoffer B.J., Westphal H., Tomac A.C. Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis 2006, 44:383-390.
3. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2001, 2:325-334.
4. Beal M.F. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 2003, 991:120-131.
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
6. Binder C.J., Weiher H., Exner M., Kerjaschki D. Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: a model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am. J. Pathol. 1999, 154:1067-1075.
7. Bloem B.R., Irwin I., Buruma O.J., Haan J., Roos R.A., Tetrud J.W., Langston J.W. The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J. Neurol. Sci. 1990, 97:273-293.
8. Colotla V.A., Flores E., Oscos A., Meneses A., Tapia R. Effects of MPTP on locomotor activity in mice. Neurotoxicol. Teratol. 1990, 12:405-407.
9. Dell K.M., Li Y.X., Peng M., Neilson E.G., Gasser D.L. Localization of the mouse kidney disease (kd) gene to a YAC/BAC contig on Chromosome 10. Mamm. Genome 2000, 11:967-971.
10. Falk M.J., Polyak E., Zhang Z., Peng M., King R., Maltzman J.S., Okwuego E., Horyn O., Nakamaru-Ogiso E., Ostrovsky J., Xie L.X., Chen J.Y., Marbois B., Nissim I., Clarke C.F., Gasser D.L. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol. Med. 2011, 3:410-427.
11. Goldberg M.S., Fleming S.M., Palacino J.J., Cepeda C., Lam H.A., Bhatnagar A., Meloni E.G., Wu N., Ackerson L.C., Klapstein G.J., Gajendiran M., Roth B.L., Chesselet M.F., Maidment N.T., Levine M.S., Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 2003, 278:43628-43635.
12. Henchcliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 2008, 4:600-609.
13. Lemieux H., Gneiger E. Preparation of permeabilized muscle fibers for diagnosis of mitochondrial respiratory function. Mitochondrial Physiol. Netw. 2008, 12(22):1-4.
14. Lemieux H., Votion M.-D., Gneiger E. Mitochondrial respiration in permeabilized fibers: needle biopsies from horse skeletal muscle. Mitochondrial Physiology Network 2009, 12(23):1-4.
15. Lopez L.C., Schuelke M., Quinzii C.M., Kanki T., Rodenburg R.J., Naini A., Dimauro S., Hirano M. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 2006, 79:1125-1129.
16. Lyon M.F., Hulse E.V. An inherited kidney disease of mice resembling human nephronophthisis. J. Med. Genet. 1971, 8:41-48.
17. Matsuura K., Kabuto H., Makino H., Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J. Neurosci. Methods 1997, 73(1):45-48.
18. Peng M., Jarett L., Meade R., Madaio M.P., Hancock W.W., George A.L., Neilson E.G., Gasser D.L. Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int. 2004, 66:20-28.
19. Peng M., Falk M.J., Haase V.H., King R., Polyak E., Selak M., Yudkoff M., Hancock W.W., Meade R., Saiki R., Lunceford A.L., Clarke C.F., Gasser D.L. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet. 2008, 4:e1000061.
20. Rozas G., Lopez-Martin E., Guerra M.J., Labandeira-Garcia J.L. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J. Neurosci. Methods 1998, 83:165-175.
21. Saiki R., Nagata A., Kainou T., Matsuda H., Kawamukai M. Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans. FEBS J. 2005, 272:5606-5622.
22. kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal Physiol. 2008, 295:F1535-F1544.
23. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994, 59:401-415.
24. Sedelis M., Schwarting R.K., Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain Res. 2001, 125:109-125.
25. Shults C.W., Haas R.H., Passov D., Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 1997, 42:261-264.
26. Zhang Z., Gasser D.L., Rappaport E.F., Falk M.J. Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy. Mol. Genet. Metab. 2010, 99:309-318.